Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance

Mass vaccination campaigns against COVID-19 affected more than 90% of the population in most developed countries. The new epidemiologic wave of COVID-19 has been ongoing since the end of 2021. It is caused by a virus variant B.1.1.529, also known as “Omicron” and its descendants. The effectiveness o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shkoda, Andrey S., Gushchin, Vladimir A., Ogarkova, Darya A., Stavitskaya, Svetlana V., Orlova, Olga E., Kuznetsova, Nadezhda A., Keruntu, Elena N., Pochtovyi, Andrei A., Pukhov, Alexander V., Kleymenov, Denis A., Krzhanovsky, Vasyli G., Vasina, Daria V., Shkuratova, Nataliya V., Shidlovskaya, Elena V., Gorbunov, Alexey L., Kustova, Daria D., Mazurina, Evgeniya A., Kozlova, Sofya R., Soboleva, Alexandra V., Grigoriev, Igor V., Pankratyeva, Lyudmila L., Odintsova, Alina S., Belyaeva, Elizaveta D., Bessonova, Arina A., Vasilchenko, Lyudmila A., Lupu, Igor P., Adgamov, Ruslan R., Tkachuk, Artem P., Tokarskaya, Elizaveta A., Logunov, Denis Y., Gintsburg, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227631/
https://www.ncbi.nlm.nih.gov/pubmed/35746546
http://dx.doi.org/10.3390/vaccines10060938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227631/
https://www.ncbi.nlm.nih.gov/pubmed/35746546
http://dx.doi.org/10.3390/vaccines10060938

Ejemplares similares